$RGNX $TNYA - 5 Cardio Gene Therapies on the Near Horizon biospace.com/drug-developme…

This is going to change things #xbi $xbi congress.gov/bill/119th-con…

The last mile of AI is healthcare, like curing cancer, it has to be… everything else is just a pit stop #xbi

$TNYA Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine stocktitan.net/news/TNYA/tena…

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine $TNYA tinyurl.com/29olryse

𝗜𝘁’𝘀 𝘁𝗶𝗺𝗲 𝘁𝗼 𝗳𝗶𝘅 𝘁𝗲𝗻𝗻𝗶𝘀. Today, the PTPA and over a dozen players, on behalf of the entire professional population, filed a sweeping series of legal actions against the ATP, WTA, ITF and ITIA to reform professional tennis. ptpaplayers.com/legal-actions-…

Tennis appears to be a glamorous sport for well-compensated athletes. The reality is a loss-making, health-threatening grind for all but the top 100 or so players. The failure of the sport to provide for the basic needs and rights of the players is due to the corrupt leadership

much better than tariffs, would be to incentivize reshoring of manufacturing by making manufacturing plants 2x deductible against corporate taxes. everyone would do it, because the federal government would essentially pay you back for making the investment.

remarks from pascal, ceo of Astra, on their earnings call this morning that sums up current state of eu drug market well: "the US has been funding innovation for our industry for a long time. and we believe that europe has to invest a greater share of their healthcare expenses,

This is exactly why PBMs should not be allowed to offer Formularies. Excluding zepbound is as pay for play as it gets, and has nothing to do with clinical value to patients. It takes the control of patient wellness out of the hands of doctors and patients and into the hands of

Going after high drug costs means going after PBM’s owned by insurance companies. THEY are the real cause of high drug prices.

$rckt presents PKP2 gene therapy data at asgct. One patient experienced grade 4 sepsis, good news is there is protein expression. Mixed data?

𝐀𝐒𝐆𝐂𝐓 𝟐𝟎𝟐𝟓: Physicians and scientists raced to make a bespoke gene editing therapy for an infant who urgently needed one in months - a first hand account by Kiran Musunuru. #ASGCT2025 Full video: biotechtv.com/post/kiran-mus…

Big news from the team at Strand Therapeutics: Our lead mRNA therapeutic, STX-001, has shown positive Phase 1 data in patients with advanced solid tumors. This is a milestone that’s both scientific and deeply personal. 🧵

Stanley Zhong had a 4.42 GPA, a 1590 SAT, and ranked in the top 1% of the USA Computing Olympiad (Platinum). He built a free e-signing platform, reached the semifinals of Google Code Jam, and placed 2nd in MIT’s Battlecode. Still, 15 of 18 colleges rejected him — including

No words - only tears of joy. And bow of gratitude to Rebecca Ahrens-nicklas (CHOP) and Kiran Musunuru (Penn) and Sadik Kassim (Danaher) - our amazing partners in designing, derisking, and administering a CRISPR on demand to Baby KJ.

Otsuka tops Vera Therapeutics $VERA in kidney disease study showdown statnews.com/2025/06/06/ots…

No eGFR data yet. But must be painful for Vera. Monthly PFS vs weekly AI. Otsuka knows the nephrology community well so will be uphill commercial battle for Vera

The mission to Make America Healthy Again (MAHA) includes MABA — Make American Biotech Accelerate. President Trump showed in his first term what happens when you unlock American science — breakthroughs happen fast. Now, we’re going to do it again. We know the power of U.S.

MABA